<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272660</url>
  </required_header>
  <id_info>
    <org_study_id>S-503</org_study_id>
    <nct_id>NCT02272660</nct_id>
  </id_info>
  <brief_title>Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty</brief_title>
  <official_title>Perioperative Parecoxib Administration for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty-A Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluated the effect of perioperative parecoxib administration on postoperative pain,
      analgesic use, function recovery, inflammatory response and bleeding risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-steroid anti-inflammatory drugs are recommended for multimodal postoperative pain
      management.

      We evaluated the effect of perioperative parecoxib administration on postoperative pain,
      analgesic use, function recovery, inflammatory response and bleeding risk.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the Morphine consumption in each group patients</measure>
    <time_frame>4 hours to 6 days after the surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate Patient-Controlled Intravenous Analgesia (PCIA) duration</measure>
    <time_frame>4 hours to 6 days after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the Visual Analog Scale (VAS) in each group patients underwent total knee arthroplasty and total hip arthroplasty</measure>
    <time_frame>4 hours to 6 days after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function recovery of knee Range of Motion (ROM) for patients received surgery</measure>
    <time_frame>3 and 6 days after the surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Testing of body temperature,routine blood examination, IL-6 and IL-10</measure>
    <time_frame>hospital admission and 1, 3, 6 days after the surgery</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Parecoxib sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in the parecoxib group received a single 40mg dose of parecoxib sodium 30 minutes before incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group received 2 mL normal saline injection at the same time point.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Parecoxib sodium</intervention_name>
    <description>The patients in the parecoxib group received a single 40mg dose of parecoxib sodium 30 minutes before incision, 9:00 pm on the operation day as well as 9:00 am and 9:00 pm for the next two days after the operation, along with PCIA morphine.</description>
    <arm_group_label>Parecoxib sodium</arm_group_label>
    <other_name>Dynastat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline injection</intervention_name>
    <description>The patients in the control group received 2 mL normal saline injection 30 minutes before Normal saline injection incision, 9:00 pm on the operation day as well as 9:00 am and 9:00 pm for the next two days after the operation, along with PCIA morphine.</description>
    <arm_group_label>Normal saline injection</arm_group_label>
    <other_name>Physiological saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients who have underwent primary unilateral total knee arthroplasty
             (TKA) and total hip arthroplasty (THA).

          2. Age between 18-65 years.

          3. Chinese ethnicity.

        Exclusion Criteria:

          1. patients who underwent a reversion or a previous TKA or THA, emergency TKA, or TKA as
             result of a trauma.

          2. patient exhibited allergy to parecoxib sodium.

          3. lactating or pregnant.

          4. any other conditions not suitable for surgery as evaluated by the surgeon in charge.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhihong Wu, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>PUMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100005</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>August 27, 2015</last_update_submitted>
  <last_update_submitted_qc>August 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Zhihong Wu</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>preemptive analgesia</keyword>
  <keyword>parecoxib sodium</keyword>
  <keyword>total knee arthroplasty</keyword>
  <keyword>total hip arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

